Life Sciences & Biotechnology
Title: | DNA Vaccine as Immune-prophylaxis Against Kala-azar |
Area: | Medical Sciences, Life Sciences & Biotechnology |
Focus Area: | Genetic Immunization against Kala-azar |
Patent: | US8524677 |
Social Benefits: | An indigenous technology having immense prophylactic potential; WHO has identified leishmaniasis as a major and increasing public health problem. Available chemotherapeutic strategies emerging resistant strains and lack of an effective vaccine against Kala-azar intensifies the crisis; The vaccine prevents mortality of the mammal from lethal virulent Leishmania infection and confers sterile protection in tissues that would be infected by Leishmaniaupon exposure. |
Developing Agency: | CSIR-Indian Institute of Chemical Biology (IICB), West Bengal |
Technology Readiness Index: | Lab Validation |
Email: | director@iicb.res.in |
| Website Link : | http://www.iicb.res.in |
| Source (more info) : | https://t.ly/l_sb |
Brief Description
Description : | The technology uses a highly conserved membrane protein present in all species of Leishmania as a vaccine antigen for genetic immunization against visceral leishmananiasis or Kala-azar. |
Related Technologies